Which international regulatory approach often emphasizes the need for scientific certainty before implementing strict controls on nanotechnology products?
Question 2
What is the primary challenge in establishing a universally accepted definition of 'nanomaterial' for regulatory purposes?
Question 3
Which of the following best describes the 'life cycle assessment' (LCA) approach in the regulatory framework for nanotechnology products?
Question 4
Consider a scenario where a new nanomaterial is developed for use in medical implants. Which regulatory principle would be most emphasized during its approval process?
Question 5
What is the primary role of 'registries' or 'inventories' of nanomaterials in national regulatory frameworks?
